Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Serum Repressor Element-1 Silencing Transcription Factor Levels in Alzheimer's Patients from a National Institute of Health in Mexico City, Elderly and Young Controls

Ramírez-Cuapio FL, Torres-Ramos MA, Orozco-Ibarra M, Acosta I, Sosa-Ortiz AL.

Rev Invest Clin. 2020 May 7;73(1):017-022. doi: 10.24875/RIC.20000089.

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI).

Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3.

Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration

Busatto Filho G, Duran FLS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGDF, da Costa NA, Porto FHG, Carvalho CL, Brucki SMD, Nitrini R, Forlenza OV, Leite CDC, Buchpiguel CA, de Paula Faria D.

J Neurosci Res. 2021 Feb;99(2):481-501. doi: 10.1002/jnr.24739. Epub 2020 Oct 18.

Retinal imaging in Alzheimer's and neurodegenerative diseases

Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, DeBuc DC, Campbell MCW, Carrillo MC, Chew EY, Cordeiro MF, Dueñas MR, Fernández BM, Koronyo-Hamaoui M, La Morgia C, Carare RO, Sadda SR, van Wijngaarden P, Snyder HM.

Alzheimers Dement. 2021 Jan;17(1):103-111. doi: 10.1002/alz.12179. Epub 2020 Oct 8.

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Schöll M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative.

Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Atlante A, Amadoro G, Bobba A, Latina V.

Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347.

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L.

Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037. doi: 10.1016/j.tips.2020.09.011. Epub 2020 Oct 27.

Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E.

Crit Rev Clin Lab Sci. 2021 May;58(3):167-179. doi: 10.1080/10408363.2020.1833298. Epub 2020 Nov 2.

Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases

Li K, Chen Z, Zhang Y, Yang X.

Curr Protein Pept Sci. 2020;21(12):1202-1217. doi: 10.2174/1389203721666201103085704.

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Dulewicz M, Kulczyńska-Przybik A, Mroczko B.

Int J Mol Sci. 2020 Nov 6;21(21):8335. doi: 10.3390/ijms21218335.

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data

Shigemizu D, Akiyama S, Higaki S, Sugimoto T, Sakurai T, Boroevich KA, Sharma A, Tsunoda T, Ochiya T, Niida S, Ozaki K.

Alzheimers Res Ther. 2020 Nov 10;12(1):145. doi: 10.1186/s13195-020-00716-0.

Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer's Disease

Zhou B, Fukushima M.

Int J Mol Sci. 2020 Nov 17;21(22):8661. doi: 10.3390/ijms21228661.

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

[Analysis of cerebrospinal fluid in the diagnosis of cognitive impairment and dementia]

Frederiksen KS, Hasselbalch S, Waldemar G.

Ugeskr Laeger. 2020 Nov 2;182(45):V05200352.

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Funnell C, Feldman HH, Mackenzie IRA, DeMarco ML.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):357-359. doi: 10.1097/WAD.0000000000000372.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias